Heat shock protein 27 and its regulatory molecules express differentially in SLE patients with distinct autoantibody profiles

Immunology Letters

Volumn 164, Issue 1, 2015, Pages 25-32

  Rai, Richa ^a   Chauhan, Sudhir Kumar ^a   Singh, Vikas Vikram ^a   Rai, Madhukar ^b   Rai, Geeta ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; Brn3; Extractable nuclear antigens; Heat shock protein 27; Hsa miR 939; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CASPASE 3; DOUBLE STRANDED DNA ANTIBODY; EXTRACTABLE NUCLEAR ANTIGEN ANTIBODY; HEAT SHOCK PROTEIN 27; HSA MIR 939; MESSENGER RNA; MICRORNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR POU4F1; UNCLASSIFIED DRUG; ANTI-EXTRACTABLE NUCLEAR ANTIGEN ANTIBODIES; ANTINUCLEAR ANTIBODY; POU4F1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; CASE CONTROL STUDY; CHEMISTRY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CASE-CONTROL STUDIES; CASPASE 3; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; MIDDLE AGED; POLY(ADP-RIBOSE) POLYMERASES; TRANSCRIPTION FACTOR BRN-3A; YOUNG ADULT;

EID: 84923252657     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2015.01.007     Document Type: Article

References (47)

1. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
2. To C.H., Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus. Arthritis Rheum 2005, 52:4003-4010.
3. Chauhan S.K., Singh V.V., Rai R., Rai M., Rai G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol 2013, 33:954-964.
4. Chauhan S.K., Singh V.V., Rai R., Rai M., Rai G. Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities. J Clin Immunol 2014, 34:491-503.
5. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008, 15:183-191.
6. Perniok A., Wedekind F., Herrmann M., Specker C., Schneider M. High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998, 7:113-118.
7. Courtney P.A., Crockard A.D., Williamson K., McConnell J., Kennedy R.J., Bell A.L. Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity. Lupus 1999, 8:508-513.
8. Courtney P.A., Crockard A.D., Williamson K., Irvine A.E., Kennedy R.J., Bell A.L. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999, 58:309-314.
9. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250.
10. Ren Y., Tang J., Mok M.Y., Chan A.W., Wu A., Lau C.S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2888-2897.
11. Garrido C., Bruey J.M., Fromentin A., Hammann A., Arrigo A.P., Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 1999, 13:2061-2070.
12. Sreedhar A.S., Csermely P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol Ther 2004, 101:227-257.
13. Lanneau D., Brunet M., Frisan E., Solary E., Fontenay M., Garrido C. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 2008, 12:743-761.
14. Ricci J.E., Maulon L., Battaglione-Hofman V., Bertolotto C., Luciano F., Mari B., et al. A Jurkat T cell variant resistant to death receptor-induced apoptosis. Correlation with heat shock protein (Hsp) 27 and 70 levels. Eur Cytokine Netw 2001, 12:126-134.
15. Romano C.C., Benedetto N., Catania M.R., Rizzo A., Galle F., Losi E., et al. Commonly used antibiotics induce expression of Hsp 27 and Hsp 60 and protect human lymphocytes from apoptosis. Int Immunopharmacol 2004, 4:1067-1073.
16. Gibbons N.B., Watson R.W., Coffey R.N., Brady H.P., Fitzpatrick J.M. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 2000, 45:58-65.
17. Zoubeidi A., Gleave M. Small heat shock proteins in cancer therapy and prognosis. Int J Biochem Cell Biol 2012, 44:1646-1656.
18. Voll E.A., Ogden I.M., Pavese J.M., Huang X., Xu L., Jovanovic B.D., et al. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget 2014, 5:2648-2663.
19. Sedlackova L., Sosna A., Vavrincova P., Frydl J., Guerriero V., Raynes D.A., et al. Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls. Scand J Rheumatol 2011, 40:354-357.
20. Aquino D.A., Capello E., Weisstein J., Sanders V., Lopez C., Tourtellotte W.W., et al. Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. J Neuropathol Exp Neurol 1997, 56:664-672.
21. Lee S.A., Ndisang D., Patel C., Dennis J.H., Faulkes D.J., D'Arrigo C., et al. Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res 2005, 65:3072-3080.
22. Farooqui-Kabir S.R., Diss J.K., Henderson D., Marber M.S., Latchman D.S., Budhram-Mahadeo V., et al. Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression. Cell Stress Chaperones 2008, 13:297-312.
23. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
24. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
26. Havasi A., Li Z., Wang Z., Martin J.L., Botla V., Ruchalski K., et al. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2008, 283:12305-12313.
27. Wood K.L., Voss O.H., Huang Q., Parihar A., Mehta N., Batra S., et al. The small heat shock protein 27 is a key regulator of CD8+ CD57+ lymphocyte survival. J Immunol 2010, 184:5582-5588.
28. Jin O., Sun L.Y., Zhou K.X., Zhang X.S., Feng X.B., Mok M.Y., et al. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumatol 2005, 24:107-110.
29. Amasaki Y., Kobayashi S., Takeda T., Ogura N., Jodo S., Nakabayashi T., et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 1995, 99:245-250.
30. Lub-de Hooge M.N., de Vries E.G., de Jong S., Bijl M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 2005, 64:854-858.
31. Kaplan M.J., Lewis E.E., Shelden E.A., Somers E., Pavlic R., McCune W.J., et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol 2002, 169:6020-6029.
32. Tan C.Y., Ban H., Kim Y.H., Lee S.K. The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis. Mol Cells 2009, 27:533-538.
33. Nahomi R.B., Palmer A., Green K.M., Fort P.E., Nagaraj R.H. Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells. Biochim Biophys Acta 2014, 1842:164-174.
34. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516.
35. Farooqui-Kabir S.R., Budhram-Mahadeo V., Lewis H., Latchman D.S., Marber M.S., Heads R.J. Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a. Cell Death Differ 2004, 11:1242-1244.
36. Thomas D., Tyers M. Transcriptional regulation: kamikaze activators. Curr Biol 2000, 10:R341-R343.
37. Trieu M., Ma A., Eng S.R., Fedtsova N., Turner E.E. Direct autoregulation and gene dosage compensation by POU-domain transcription factor Brn3a. Development 2003, 130:111-121.
38. Smith M.D., Melton L.A., Ensor E.A., Packham G., Anderson P., Kinloch R.A., et al. Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro. Mol Cell Neurosci 2001, 17:460-470.
39. Ensor E., Smith M.D., Latchman D.S. The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis. J Biol Chem 2001, 276:5204-5212.
40. Guo Z., Shao L., Zheng L., Du Q., Li P., John B., et al. miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc Natl Acad Sci U S A 2012, 109:5826-5831.
41. de Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris S.M., et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A 1996, 93:1054-1059.
42. Davas E.M., Tsirogianni A., Kappou I., Karamitsos D., Economidou I., Dantis P.C. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 1999, 18:17-22.
43. Gomez D., Correa P.A., Gomez L.M., Cadena J., Molina J.F., Anaya J.M. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective. Semin Arthritis Rheum 2004, 33:404-413.
44. Ohl K., Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol 2011, 432595.
45. Villalobos-Hurtado R., Sanchez-Rogriguez S.H., Avalos-Diaz E., Herrera-Esparza R. Possible role of Hsp70 in autoantigen shuttling to the dermo-epidermal junction in systemic lupus erythematosus. Reumatismo 2003, 55:155-158.
46. Sanchez-Rodriguez S.H., Herrera-van Oostdam D., Avalos-Diaz E., Herrera-Esparza R. Ro60 and La ribonucleoproteins become self-aggregated by cell stress. Reumatismo 2007, 59:292-298.
47. Furukawa F., Ikai K., Matsuyoshi N., Shimizu K., Imamura S. Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. J Invest Dermatol 1993, 101:191-195.